γ-Tocotrienol Suppression of the Warburg Effect Is Mediated by AMPK Activation in Human Breast Cancer Cells

References

• Evan GI and Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342–348, 2001.
   PubMed Web of Science ®Google Scholar
• Keibler MA, Wasylenko TM, Kelleher JK, Iliopoulos O, Vander Heiden MG, et al.: Metabolic requirements for cancer cell proliferation. Cancer Metab 4, 16, 2016.
   PubMed Web of Science ®Google Scholar
• Cairns RA, Harris IS, and Mak TW: Regulation of cancer cell metabolism. Nat Rev Cancer 11, 85–95, 2011.
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Lum JJ, Hatzivassiliou G, and Thompson CB: The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7, 11–20, 2008.
   PubMed Web of Science ®Google Scholar
• Pavlova NN and Thompson CB: The emerging hallmarks of cancer metabolism. Cell Metab 23, 27–47, 2016.
   PubMed Web of Science ®Google Scholar
• Warburg O: On the origin of cancer cells. Science 123, 309–314, 1956.
   PubMed Web of Science ®Google Scholar
• Goodwin ML, Gladden LB, Nijsten MW, and Jones KB: Lactate and cancer: revisiting the Warburg effect in an era of lactate shuttling. Front Nutr 1, 27, 2014.
   PubMedGoogle Scholar
• Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, et al.: Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64, 3892–3899, 2004.
   PubMed Web of Science ®Google Scholar
• Faubert B, Boily G, Izreig S, Griss T, Samborska B, et al.: AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab 17, 113–124, 2013.
   PubMed Web of Science ®Google Scholar
• Hardie DG: Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 144, 5179–5183, 2003.
   PubMed Web of Science ®Google Scholar
• Fogarty S and Hardie DG: Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim Biophys Acta 1804, 581–591, 2010.
   PubMed Web of Science ®Google Scholar
• Steinberg GR and Kemp BE: AMPK in Health and Disease. Physiol Rev 89, 1025–1078, 2009.
   PubMed Web of Science ®Google Scholar
• Sylvester PW, Akl MR, Malaviya A, Parajuli P, Ananthula S, et al.: Potential role of tocotrienols in the treatment and prevention of breast cancer. Biofactors 40, 49–58, 2014.
   PubMed Web of Science ®Google Scholar
• McIntyre BS, Briski KP, Gapor A, and Sylvester PW: Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Biol Med 224, 292–301, 2000.
   PubMed Web of Science ®Google Scholar
• O'Byrne D, Grundy S, Packer L, Devaraj S, Baldenius K, et al.: Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans. Free Radic Biol Med 29, 834–845, 2000.
   PubMed Web of Science ®Google Scholar
• Alawin OA, Ahmed RA, Ibrahim BA, Briski KP, and Sylvester PW: Antiproliferative effects of gamma-tocotrienol are associated with lipid raft disruption in HER2-positive human breast cancer cells. J Nutr Biochem 27, 266–277, 2016.
   PubMed Web of Science ®Google Scholar
• Ayoub NM, Bachawal SV, and Sylvester PW: gamma-Tocotrienol inhibits HGF-dependent mitogenesis and Met activation in highly malignant mammary tumour cells. Cell Prolif 44, 516–526, 2011.
   PubMed Web of Science ®Google Scholar
• Tiwari RV, Parajuli P, and Sylvester PW: gamma-Tocotrienol-induced endoplasmic reticulum stress and autophagy act concurrently to promote breast cancer cell death. Biochem Cell Biol 12, 1–15, 2015.
   Google Scholar
• Wali VB, Bachawal SV, and Sylvester PW: Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1. Exp Biol Med (Maywood) 234, 639–650, 2009.
   PubMed Web of Science ®Google Scholar
• Wali VB, Bachawal SV, and Sylvester PW: Endoplasmic reticulum stress mediates gamma-tocotrienol-induced apoptosis in mammary tumor cells. Apoptosis 14, 1366–1377, 2009.
   PubMed Web of Science ®Google Scholar
• Weng-Yew W, Selvaduray KR, Ming CH, and Nesaretnam K: Suppression of tumor growth by palm tocotrienols via the attenuation of angiogenesis. Nutr Cancer 61, 367–373, 2009.
   PubMed Web of Science ®Google Scholar
• Parajuli P, Tiwari RV, and Sylvester PW : Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis . Biol Pharm Bull 38, 1352–1360, 2015.
   PubMed Web of Science ®Google Scholar
• Parajuli P, Tiwari RV, and Sylvester PW: Anti-proliferative effects of gamma-tocotrienol are associated with suppression of c-Myc expression in mammary tumour cells. Cell Prolif 48, 421–435, 2015.
   PubMed Web of Science ®Google Scholar
• Tiwari RV, Parajuli P, and Sylvester PW: gamma-Tocotrienol-induced autophagy in malignant mammary cancer cells. Exp Biol Med (Maywood) 239, 33–44, 2014.
   PubMed Web of Science ®Google Scholar
• Bachawal SV, Wali VB, and Sylvester PW: Combined gamma-tocotrienol and erlotinib/gefitinib treatment suppresses Stat and Akt signaling in murine mammary tumor cells. Anticancer Res 30, 429–437, 2010.
   PubMed Web of Science ®Google Scholar
• Shah SJ and Sylvester PW: Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity. Exp Biol Med (Maywood) 230, 235–241, 2005.
   PubMed Web of Science ®Google Scholar
• Towbin H, Staehelin T, and Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76, 4350–4354, 1979.
   PubMed Web of Science ®Google Scholar
• Weinhouse S: The Warburg hypothesis fifty years later. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 87, 115–126, 1976.
   PubMedGoogle Scholar
• Fantin VR, St-Pierre J, and Leder P: Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9, 425–434, 2006.
   PubMed Web of Science ®Google Scholar
• Fruman DA and Rommel C: PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov 13, 140–156, 2014.
   PubMed Web of Science ®Google Scholar
• Hajduch E, Litherland GJ, and Hundal HS: Protein kinase B (PKB/Akt)-a key regulator of glucose transport? FEBS Lett 492, 199–203, 2001.
   PubMed Web of Science ®Google Scholar
• Testa JR and Tsichlis PN: AKT signaling in normal and malignant cells. Oncogene 24, 7391–7393, 2005.
   PubMed Web of Science ®Google Scholar
• Luo A, Zang M, and Guo W: AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol 6, 457–470, 2010.
   PubMed Web of Science ®Google Scholar
• Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, et al.: LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13, 2004–2008, 2003.
   PubMed Web of Science ®Google Scholar
• Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, et al.: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857–868, 1999.
   PubMed Web of Science ®Google Scholar
• Chiacchiera F and Simone C: The AMPK-FoxO3A axis as a target for cancer treatment. Cell Cycle 9, 1091–1096, 2010.
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, and Guan K-L: AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13, 132–141, 2011.
   PubMed Web of Science ®Google Scholar
• LoRusso PM: Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors. J Clin Oncol 34, 3803–3815, 2016.
   PubMed Web of Science ®Google Scholar
• Tzivion G, Dobson M, and Ramakrishnan G: FoxO transcription factors; Regulation by AKT and 14-3-3 proteins. Biochim Biophys Acta 1813, 1938–1945, 2011.
   PubMed Web of Science ®Google Scholar
• Burgering BMT: A brief introduction to FOXOlogy. Oncogene 27, 2258–2262, 2008.
   PubMed Web of Science ®Google Scholar
• Emerling BM, Weinberg F, Liu JL, Mak TW, and Chandel NS: PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a). Proc Natl Acad Sci USA 105, 2622–2627, 2008.
   PubMed Web of Science ®Google Scholar
• Ananthula S, Parajuli P, Behery FA, Alayoubi AY, Nazzal S, et al. delta-Tocotrienol oxazine derivative antagonizes mammary tumor cell compensatory response to CoCl2-induced hypoxia. Biomed Res Int 2014, 285752, 2014.
   PubMedGoogle Scholar
• Greer EL, Oskoui PR, Banko MR, Maniar JM, Gygi MP, et al. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem 282, 30107–30119, 2007.
   PubMed Web of Science ®Google Scholar
• Clark AR and Toker A: Signalling specificity in the Akt pathway in breast cancer. Biochm Soc Trans 42, 1349–1355, 2014.
   PubMed Web of Science ®Google Scholar
• Clarke MW, Burnett JR, and Croft KD: Vitamin E in Human Health and Disease. Crit Rev Clin Lab Sci 45, 417–450, 2008.
   PubMed Web of Science ®Google Scholar
• Garrido P, Osorio FG, Moran J, Cabello E, Alonso A, et al.: Loss of GLUT4 induces metabolic reprogramming and impairs viability of breast cancer cells. J Cell Physiol 230, 191–198, 2015.
   PubMed Web of Science ®Google Scholar